Aclaris Therapeutics Inc buy krebskrebs
Start price
17.04.24
/
50%
€1.14
Target price
17.04.25
€3.00
Performance (%)
-5.12%
Price
25.04.24
€1.11
Summary
This prediction is currently active. With a performance of -5.12%, the BUY prediction for Aclaris Therapeutics Inc by krebskrebs is down slightly. This prediction currently runs until 17.04.25. The prediction end date can be changed by krebskrebs at any time. krebskrebs has 50% into this predictionPerformance without dividends (%)
Name | 1w |
---|---|
Aclaris Therapeutics Inc | -3.130% |
iShares Core DAX® | 0.961% |
iShares Nasdaq 100 | 2.626% |
iShares Nikkei 225® | 0.217% |
iShares S&P 500 | 1.540% |
Comments by krebskrebs for this prediction
In the thread Aclaris Therapeutics Inc diskutieren
Buy mit Kursziel 3,0